跳至主要内容
临床试验/CTRI/2015/06/005911
CTRI/2015/06/005911招募中未知

Comparative Study Of Serum Procalcitonin Level In STEMI Patients Undergoing Primary PTCA vs Thrombolysis and To Correlate With In-hospital Outcomes

CMC fluid research funding0 个研究点目标入组 102 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
102

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Patients with age more than 18 years, presented with acute ST elevation myocardial infarction (STEMI) and eligible for reperfusion therapy as per STEMI protocol will be included in the study after taking informed consent. Acute STEMI will be diagnosed based on universal deï¬?nition of myocardial infarction.

排除标准

  • STEMI patients in whom thrombolysis or primary PTCA not indicated according to guidelines like late presentation
  • STEMI patients undergo Pharmacoinvasive PTCA
  • Patients with acute or chronic inflammatory diseases, those with bacterial infections & sepsis and patients taking steroidal or non-steroidal anti-inflammatory drugs
  • Patients with significant underlying other systemic disorders like chronic renal or hepatic or respiratory failure and malignancy
  • Patients underwent any surgery in the last 4 weeks before STEMI
  • Pregnant female presented with STEMI

研究者

发起方
CMC fluid research funding

相似试验